You are here: Home » News-CM » Companies » Results
Business Standard

Kilitch Drugs (India) standalone net profit declines 84.65% in the June 2019 quarter

Capital Market 

Sales decline 57.17% to Rs 11.98 crore

Net profit of Kilitch Drugs (India) declined 84.65% to Rs 0.64 crore in the quarter ended June 2019 as against Rs 4.17 crore during the previous quarter ended June 2018. Sales declined 57.17% to Rs 11.98 crore in the quarter ended June 2019 as against Rs 27.97 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales11.9827.97 -57 OPM %-4.0111.55 -PBDT1.125.60 -80 PBT0.905.34 -83 NP0.644.17 -85

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, August 14 2019. 15:44 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU